ABVC
ABVC Biopharma Inc
NASDAQ: ABVC · HEALTHCARE · BIOTECHNOLOGY
$1.03
-3.74% today
Updated 2026-04-29
Market cap
$26.41M
P/E ratio
—
P/S ratio
27.42x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$1 – $5
Volume
0.1M
ABVC Biopharma Inc (ABVC) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
+579.5%
Most recent quarter
EPS YoY growth
+44.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.7%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+0.7%
2025-11-03
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-03 | $-0.05 | — | $2.80 | $2.82 | +0.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 | $-0.05 | — | $795950.00 | +104.5% |
| 2025-06-30 | $0.00 | $-0.13 | — | — | — |
| 2025-03-31 | $0.00 | $0.02 | — | $1966.00 | +63.2% |
| 2024-09-30 | — | $-0.02 | — | $389276.00 | +2350.7% |
| 2024-06-30 | — | $-0.09 | — | $117142.00 | +1817.5% |
| 2024-03-31 | — | $-0.40 | — | $1205.00 | -99.1% |
| 2023-12-31 | — | $-0.39 | — | $2165.00 | — |
| 2023-09-30 | $-0.04 | $-0.82 | -1945.3% | $15884.00 | — |
| 2023-06-30 | $-0.06 | $-0.68 | -1040.2% | $6109.00 | — |
| 2023-03-31 | $-0.05 | $-0.06 | -20.0% | $128272.00 | — |
| 2022-12-31 | $-0.15 | $-0.15 | +0.0% | — | — |
| 2022-09-30 | $-0.12 | $-0.11 | +8.3% | — | — |
| 2022-06-30 | $-0.12 | $-0.06 | +50.0% | — | — |
Frequently asked questions
Has ABVC Biopharma Inc beaten earnings estimates?
ABVC Biopharma Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports.
How does ABVC stock react to earnings?
ABVC stock has moved an average of +0.7% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.
What is ABVC Biopharma Inc's revenue growth rate?
ABVC Biopharma Inc reported year-over-year revenue growth of +579.5% in its most recent quarter, with EPS growing +44.1% year-over-year.